Interferon Signaling and Outcomes in Triple-negative Breast Cancer in the FinXX, CALGB 40603 (Alliance), and Real-World Clinico-Genomic Data
   Google Scholar   
Citation:
Meeting Instance:
ASCO 2025
Year:
2025
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882, U24CA196171, P50CA116201-17, , W81XWH-15-1-0292, P50CA015083, R35CA253187  
Corr. Author:
 
Authors:
                                                   
Networks:
11030, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, PR028   
Study
Alliance-A152401
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40603
Phases:
N/A, 2
Keywords: